(Q46561264)

23 December 2017

title

Serum fucosylation changes in oral cancer and oral precancerous conditions: alpha-L-fucosidase as a marker (English)

1 reference

23 December 2017

lip and oral cavity carcinoma

main subject

1 reference

Manisha Shah

1

1 reference

23 December 2017

Shaila Telang

2

1 reference

23 December 2017

Gira Raval

3

1 reference

23 December 2017

Pankaj Shah

4

1 reference

23 December 2017

Prabhudas S Patel

5

1 reference

23 December 2017

language of work or name

English

0 references

publication date

1 July 2008

1 reference

23 December 2017

published in

Cancer

1 reference

23 December 2017

volume

113

1 reference

23 December 2017

issue

2

1 reference

23 December 2017

page(s)

336-346

1 reference

23 December 2017

Elevated levels of abnormally-fucosylated haptoglobins in cancer sera

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23556

Abnormally-fucosylated haptoglobin: a cancer marker for tumour burden but not gross liver metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23556

Alpha-L-fucose: a potentially critical molecule in pathologic processes including neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23556

Malignant cell glycoproteins and glycolipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23556

7 January 2021

Fucose levels in sera and in tumours of colorectal adenocarcinoma patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23556

7 January 2021

Circulating levels in serum of total sialic acid, lipid-associated sialic acid, and fucose in precancerous lesion and cancer of the oral cavity.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23556

7 January 2021

Plasma fucosyltransferase activity in patients with hepatocellular carcinoma, with special reference to correlation with fucosylated species of alpha-fetoprotein

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23556

7 January 2021

alpha1,6fucosyltransferase is highly and specifically expressed in human ovarian serous adenocarcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23556

7 January 2021

Plant lectins: occurrence, biochemistry, functions and applications.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23556

7 January 2021

Fucosylation of serum glycoproteins in lung cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23556

7 January 2021

The enzymatic basis for the conversion of nonfucosylated to fucosylated alpha-fetoprotein by acyclic retinoid treatment in human hepatoma cells: activation of alpha1-6 fucosyltransferase

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23556

7 January 2021

Up-regulation of Lewis enzyme (Fuc-TIII) and plasma-type alpha1,3fucosyltransferase (Fuc-TVI) expression determines the augmented expression of sialyl Lewis x antigen in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23556

7 January 2021

Value of the serum alpha-L-fucosidase activity in the diagnosis of colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23556

7 January 2021

Serum alpha L-fucosidase enzyme activity in ovarian and other female genital tract tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23556

7 January 2021

Preoperative serum alpha-L-fucosidase activity as a prognostic marker in colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23556

7 January 2021

Serum alpha-L-fucosidase activity and early detection of hepatocellular carcinoma: a prospective study of patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23556

7 January 2021

Aspects of cell proliferation in oral epithelial dysplastic lesions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23556

7 January 2021

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23556

7 January 2021

Cancer-associated elevation of α(1 → 3)-l-fucosyltransferase activity in human serum

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23556

7 January 2021

α-l-Fucosidase and other glycosidases in human placenta, foetus liver and amniotic fluid at various stages of gestation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23556

7 January 2021

The binding site for fucose-binding proteins of Lotus tetragonolobus is a prognostic marker for transitional cell carcinoma of the human urinary bladder

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23556

7 January 2021

Carbohydrate-mediated cell adhesion involved in hematogenous metastasis of cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23556

7 January 2021

Serum fucose as a monitor for recurrent malignancy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23556

7 January 2021

Decrease of human serum fucosyltransferase as an indicator of successful tumor therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23556

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23556

7 January 2021

Identifiers

DOI

10.1002/CNCR.23556

1 reference

23 December 2017

1 reference

23 December 2017